These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 16893411

  • 1. Dialysis-related carnitine disorder.
    Hedayati SS.
    Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
    [Abstract] [Full Text] [Related]

  • 2. Carnitine nutriture of dialysis patients.
    Borum PR, Taggart EM.
    J Am Diet Assoc; 1986 May; 86(5):644-7. PubMed ID: 3700927
    [Abstract] [Full Text] [Related]

  • 3. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.
    Sakurauchi Y, Matsumoto Y, Shinzato T, Takai I, Nakamura Y, Sato M, Nakai S, Miwa M, Morita H, Miwa T, Amano I, Maeda K.
    Am J Kidney Dis; 1998 Aug; 32(2):258-64. PubMed ID: 9708610
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they?
    Steinman TI, Nissenson AR, Glassock RJ, Dickmeyer J, Mattern WD, Parker TF, Hull AR.
    Nephrol News Issues; 2003 Apr; 17(5):28-30, 32-4, 36 passim. PubMed ID: 12715624
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Carnitine and hemodialysis.
    Bellinghieri G, Santoro D, Calvani M, Mallamace A, Savica V.
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S116-22. PubMed ID: 12612967
    [Abstract] [Full Text] [Related]

  • 12. L-carnitine supplementation in the dialysis population: are Australian patients missing out?
    Reuter SE, Faull RJ, Evans AM.
    Nephrology (Carlton); 2008 Feb; 13(1):3-16. PubMed ID: 18199095
    [Abstract] [Full Text] [Related]

  • 13. Carnitine replacement in end-stage renal disease and hemodialysis.
    Calvani M, Benatti P, Mancinelli A, D'Iddio S, Giordano V, Koverech A, Amato A, Brass EP.
    Ann N Y Acad Sci; 2004 Nov; 1033():52-66. PubMed ID: 15591003
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM, Faull R, Fornasini G, Lemanowicz EF, Longo A, Pace S, Nation RL.
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [Abstract] [Full Text] [Related]

  • 15. Dialysis-related carnitine disorder and levocarnitine pharmacology.
    Evans A.
    Am J Kidney Dis; 2003 Apr; 41(4 Suppl 4):S13-26. PubMed ID: 12751050
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.